Medical Bulletin 03/March/2026
Here are the top medical news for today:New Study Raises Health Concerns Over Popular Bubble Tea Bubble tea’s colorful presentation and chewy tapioca pearls have made it a global sensation…
Here are the top medical news for today:New Study Raises Health Concerns Over Popular Bubble Tea Bubble tea’s colorful presentation and chewy tapioca pearls have made it a global sensation…
Bengaluru: A recent assessment in Karnataka has flagged the urgent need for increased public spending, recruitment, and expansion of primary healthcare facilities to meet the growing disease burden in the…
Gujarat: In a tragic incident, a 26-year-old first-year MS Orthopedics student was found hanging in his hostel room on the Dr MK Shah Medical College campus in Chandkheda on Sunday…
Patna: In a shocking incident, a 30-year-old head nurse at Patna Medical College and Hospital (PMCH) was allegedly beaten to death by her husband at their residence in Shriram Nagar…
New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has issued a notice requiring candidates admitted to NBEMS Diploma and Post MBBS DNB Broad Speciality courses for the…
Bengaluru: The Karnataka Govt Medical Officers Association (KGMOA) has announced that doctors and healthcare personnel across all cadres will participate in a statewide agitation starting March 11, 2026, to press…
USA: Oral semaglutide may lower the risk of heart failure–related events in people with type 2 diabetes who already have heart failure, without increasing serious adverse events, a secondary analysis…
Hyderabad: To modernise medical education and ensure compliance, the Telangana Medical Council (TGMC) has launched a fully digital Continuous Professional Development (CPD) system. The platform is designed to streamline applications,…
Italy: A new cross-sectional study published in Respiratory Research has highlighted a significant association between vertebral fractures and impaired lung function in patients with interstitial lung disease (ILD), highlighting the…
A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment…